1417 related articles for article (PubMed ID: 24870351)
21. Targeting intracellular compartments by magnetic polymeric nanoparticles.
Kocbek P; Kralj S; Kreft ME; Kristl J
Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
[TBL] [Abstract][Full Text] [Related]
22. A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy.
Lv Y; Ding G; Zhai J; Guo Y; Nie G; Xu L
Colloids Surf B Biointerfaces; 2013 Oct; 110():411-8. PubMed ID: 23759382
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells.
Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812
[TBL] [Abstract][Full Text] [Related]
24. Superparamagnetic iron oxide nanoparticulate system: synthesis, targeting, drug delivery and therapy in cancer.
Palanisamy S; Wang YM
Dalton Trans; 2019 Jul; 48(26):9490-9515. PubMed ID: 31211303
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot Dissolution.
Heid S; Unterweger H; Tietze R; Friedrich RP; Weigel B; Cicha I; Eberbeck D; Boccaccini AR; Alexiou C; Lyer S
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837060
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
Mol Imaging; 2015; 14():. PubMed ID: 26044549
[TBL] [Abstract][Full Text] [Related]
27. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
[TBL] [Abstract][Full Text] [Related]
28. Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery.
Kralj S; Potrc T; Kocbek P; Marchesan S; Makovec D
Curr Med Chem; 2017; 24(5):454-469. PubMed ID: 27528059
[TBL] [Abstract][Full Text] [Related]
29. Proteomics Analysis Reveals Distinct Corona Composition on Magnetic Nanoparticles with Different Surface Coatings: Implications for Interactions with Primary Human Macrophages.
Vogt C; Pernemalm M; Kohonen P; Laurent S; Hultenby K; Vahter M; Lehtiö J; Toprak MS; Fadeel B
PLoS One; 2015; 10(10):e0129008. PubMed ID: 26444829
[TBL] [Abstract][Full Text] [Related]
30. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.
He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D
Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877
[TBL] [Abstract][Full Text] [Related]
31. Amino-polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles are suitable for monitoring of human mesenchymal stromal cells in vivo.
Schulze F; Dienelt A; Geissler S; Zaslansky P; Schoon J; Henzler K; Guttmann P; Gramoun A; Crowe LA; Maurizi L; Vallée JP; Hofmann H; Duda GN; Ode A
Small; 2014 Nov; 10(21):4340-51. PubMed ID: 24990430
[TBL] [Abstract][Full Text] [Related]
32. Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008 - present).
El-Hammadi MM; Arias JL
Expert Opin Ther Pat; 2015 Jun; 25(6):691-709. PubMed ID: 25800416
[TBL] [Abstract][Full Text] [Related]
33. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
34. Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration.
Al Faraj A; Shaik AP; Shaik AS
Nanotoxicology; 2015; 9(7):825-34. PubMed ID: 26356541
[TBL] [Abstract][Full Text] [Related]
35. Modelling the effect of SPION size in a stent assisted magnetic drug targeting system with interparticle interactions.
Mardinoglu A; Cregg PJ
ScientificWorldJournal; 2015; 2015():618658. PubMed ID: 25815370
[TBL] [Abstract][Full Text] [Related]
36. Folate-PEG-superparamagnetic iron oxide nanoparticles for lung cancer imaging.
Yoo MK; Park IK; Lim HT; Lee SJ; Jiang HL; Kim YK; Choi YJ; Cho MH; Cho CS
Acta Biomater; 2012 Aug; 8(8):3005-13. PubMed ID: 22543005
[TBL] [Abstract][Full Text] [Related]
37. Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles.
Tefft BJ; Uthamaraj S; Harburn JJ; Klabusay M; Dragomir-Daescu D; Sandhu GS
J Vis Exp; 2015 Oct; (105):e53099. PubMed ID: 26554870
[TBL] [Abstract][Full Text] [Related]
38. A superparamagnetic polymersome with extremely high T
Liu Q; Song L; Chen S; Gao J; Zhao P; Du J
Biomaterials; 2017 Jan; 114():23-33. PubMed ID: 27837682
[TBL] [Abstract][Full Text] [Related]
39. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Rosen JE; Chan L; Shieh DB; Gu FX
Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
[TBL] [Abstract][Full Text] [Related]
40. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects.
Xu HL; Mao KL; Huang YP; Yang JJ; Xu J; Chen PP; Fan ZL; Zou S; Gao ZZ; Yin JY; Xiao J; Lu CT; Zhang BL; Zhao YZ
Nanoscale; 2016 Aug; 8(29):14222-36. PubMed ID: 27396404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
